Related Experiment Video
Updated: May 26, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Alteronol inhibits proliferation in HeLa cells through inducing a G1-phase arrest
Ying Yao1, Bo Zhang, Hongmei Chen
1School of Life Sciences, Yantai University, Yantai, China.
Objectives:
Alteronol is a novel compound purified from fermentation products of a microorganism in the bark of the yew tree. The study was designed to evaluate the anticancer effects of alteronol.
Methods:
Human cervical carcinoma cell line HeLa was cultured in vitro. The cell viability was evaluated by using sulforhodamine B assay. The cell cycle distribution was analysed by flow cytometry. The level of cyclin D1 protein was evaluated using Western blot analysis. The changes in cyclinD1, CDK4 and p21 were detected by ELISA assay and the changes in G1-related regulators were detected by RT-PCR assay.
Key Findings:
Our data showed that alteronol inhibited the proliferation of HeLa cells and induced G1 phase arrest. Downregulation of the mRNA levels of CDK2, CDK4 and cyclin D1 and upregulation of p21 in alteronol-treated cells were observed.
Conclusions:
Downregulation of the mRNA levels of CDK2, CDK4 and cyclin D1 and upregulation of p21 might be a possible mechanism for the inhibition of proliferation induced by alteronol in HeLa cells.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Mitogens and the Cell Cycle

